Quote | Verve Therapeutics Inc. (NASDAQ:VERV)
Last: | $5.27 |
---|---|
Change Percent: | 1.11% |
Open: | $5.36 |
Close: | $5.27 |
High: | $5.385 |
Low: | $5.1105 |
Volume: | 1,529,919 |
Last Trade Date Time: | 06/17/2024 03:00:00 am |
News | Verve Therapeutics Inc. (NASDAQ:VERV)
2024-06-15 11:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-13 06:44:46 ET Summary Verve Therapeutics focuses on gene editing technology for one-dose therapies to reduce lipid levels related to ASCVD. VERV's pipeline includes therapies targeting genes like PCSK9, ANGPTL3, and LPA to lower ASCVD risk. Verve's leading programs, V...
Message Board Posts | Verve Therapeutics Inc. (NASDAQ:VERV)
Subject | By | Source | When |
---|---|---|---|
https://cathiesark.com/ | TheFinalCD | investorshub | 02/15/2023 12:03:17 AM |
$VERV IS A GREAT $$$$$ OPPORTUNITY. | crudeoil24 | investorshub | 06/23/2022 7:55:13 PM |
Verve Therapeutics started at outperform with $48 stock | crudeoil24 | investorshub | 06/23/2022 11:26:25 AM |
Verve Therapeutics, Inc. is a genetic medicines company, | crudeoil24 | investorshub | 06/23/2022 11:19:31 AM |
News, Short Squeeze, Breakout and More Instantly...
Verve Therapeutics Inc. Company Name:
VERV Stock Symbol:
NASDAQ Market:
2024-06-15 11:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ark Invest, led by Cathie Wood, made significant trades on Wednesday involving Robinhood Markets Inc (NASDAQ:HOOD) and Zoom Video Communications In...
Troy Lister, Ph.D., to be promoted to chief scientific officer Andrew Bellinger, M.D., Ph.D., will depart the Company and serve in an advisory cap...